Clinical Trial Update: Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants

View source ↗

Summary

A completed study examined molecular markers that could predict future lung cancer development using tissue samples from healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Healthy, no Evidence of Disease, Lung Cancer | Status: COMPLETED